Skip to main content
NCBI home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1989 Jun 15;140(12):1456–1460.

Cyclosporine-induced deterioration in patients with AIDS.

A Phillips 1, M A Wainberg 1, R Coates 1, M Klein 1, A Rachlis 1, S Read 1, F Shepherd 1, H Vellend 1, S Walmsley 1, P Halloran 1, et al.
PMCID: PMC1269983  PMID: 2720530

Abstract

Eight patients with AIDS (acquired immune deficiency syndrome) but free of life-threatening infection were treated with the immunosuppressive drug cyclosporine for a mean of 53.9 days. The serum cyclosporine levels were maintained in the desired therapeutic range. All eight patients experienced severe toxic symptoms, which necessitated discontinuation of cyclosporine therapy in six. The serum levels of creatinine, urea and potassium rose during treatment and fell after therapy was stopped. The total leukocyte count, hemoglobin level, platelet count, total T-cell count, and T4- and T8-cell counts all fell markedly during treatment. The total leukocyte count, platelet count, and T4- and T8-cell counts rose after therapy was stopped, but the hemoglobin level remained low. No patient experienced resolution of symptoms during therapy, and the condition of all patients improved after treatment was stopped. The results of this pilot study indicate that cyclosporine does not alleviate, and may worsen, the symptoms and laboratory findings in patients with AIDS.

Full text

PDF
1456

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bennett W. M., Norman D. J. Action and toxicity of cyclosporine. Annu Rev Med. 1986;37:215–224. doi: 10.1146/annurev.me.37.020186.001243. [DOI] [PubMed] [Google Scholar]
  2. Broder S., Gallo R. C. Human T-cell leukemia viruses (HTLV): a unique family of pathogenic retroviruses. Annu Rev Immunol. 1985;3:321–336. doi: 10.1146/annurev.iy.03.040185.001541. [DOI] [PubMed] [Google Scholar]
  3. Broder S., Yarchoan R., Collins J. M., Lane H. C., Markham P. D., Klecker R. W., Redfield R. R., Mitsuya H., Hoth D. F., Gelmann E. Effects of suramin on HTLV-III/LAV infection presenting as Kaposi's sarcoma or AIDS-related complex: clinical pharmacology and suppression of virus replication in vivo. Lancet. 1985 Sep 21;2(8456):627–630. doi: 10.1016/s0140-6736(85)90002-9. [DOI] [PubMed] [Google Scholar]
  4. Fischl M. A., Richman D. D., Grieco M. H., Gottlieb M. S., Volberding P. A., Laskin O. L., Leedom J. M., Groopman J. E., Mildvan D., Schooley R. T. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med. 1987 Jul 23;317(4):185–191. doi: 10.1056/NEJM198707233170401. [DOI] [PubMed] [Google Scholar]
  5. Hirsch M. S., Kaplan J. C. Prospects of therapy for infections with human T-lymphotropic virus type III. Ann Intern Med. 1985 Nov;103(5):750–755. doi: 10.7326/0003-4819-103-5-750. [DOI] [PubMed] [Google Scholar]
  6. Klatzmann D., Montagnier L. Approaches to AIDS therapy. Nature. 1986 Jan 2;319(6048):10–11. doi: 10.1038/319010a0. [DOI] [PubMed] [Google Scholar]
  7. Krown S. E., Real F. X., Cunningham-Rundles S., Myskowski P. L., Koziner B., Fein S., Mittelman A., Oettgen H. F., Safai B. Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual men with Kaposi's sarcoma. N Engl J Med. 1983 May 5;308(18):1071–1076. doi: 10.1056/NEJM198305053081806. [DOI] [PubMed] [Google Scholar]
  8. Land W., Castro L. A., White D. J., Hillebrand G., Hammer C., Klare B., Fornara P. Ciclosporin in renal transplantation. Prog Allergy. 1986;38:293–328. [PubMed] [Google Scholar]
  9. McCormick J. B., Getchell J. P., Mitchell S. W., Hicks D. R. Ribavirin suppresses replication of lymphadenopathy-associated virus in cultures of human adult T lymphocytes. Lancet. 1984 Dec 15;2(8416):1367–1369. doi: 10.1016/s0140-6736(84)92060-9. [DOI] [PubMed] [Google Scholar]
  10. Read S. E., Williams B. R., Coates R. A., Evans W. K., Fanning M. M., Garvey M. B., Shepherd F. A. Elevated levels of interferon-induced 2'-5' oligoadenylate synthetase in generalized persistent lymphadenopathy and the acquired immunodeficiency syndrome. J Infect Dis. 1985 Sep;152(3):466–472. doi: 10.1093/infdis/152.3.466. [DOI] [PubMed] [Google Scholar]
  11. Robinson W. E., Jr, Montefiori D. C., Mitchell W. M. Antibody-dependent enhancement of human immunodeficiency virus type 1 infection. Lancet. 1988 Apr 9;1(8589):790–794. doi: 10.1016/s0140-6736(88)91657-1. [DOI] [PubMed] [Google Scholar]
  12. Sandström E. Antiviral drugs for AIDS. Current status and future prospects. Drugs. 1986 Jun;31(6):463–466. doi: 10.2165/00003495-198631060-00001. [DOI] [PubMed] [Google Scholar]
  13. Shevach E. M. The effects of cyclosporin A on the immune system. Annu Rev Immunol. 1985;3:397–423. doi: 10.1146/annurev.iy.03.040185.002145. [DOI] [PubMed] [Google Scholar]
  14. Stiller C. R., Dupré J., Gent M., Jenner M. R., Keown P. A., Laupacis A., Martell R., Rodger N. W., von Graffenried B., Wolfe B. M. Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset. Science. 1984 Mar 30;223(4643):1362–1367. doi: 10.1126/science.6367043. [DOI] [PubMed] [Google Scholar]
  15. Stricker R. B., McHugh T. M., Moody D. J., Morrow W. J., Stites D. P., Shuman M. A., Levy J. A. An AIDS-related cytotoxic autoantibody reacts with a specific antigen on stimulated CD4+ T cells. 1987 Jun 25-Jul 1Nature. 327(6124):710–713. doi: 10.1038/327710a0. [DOI] [PubMed] [Google Scholar]
  16. Wainberg M. A., Blain N., Spira B. Inhibition of human lymphocyte mitogenesis by human and other retroviruses. Differential effect of interleukin-2 in restoration of responsiveness. AIDS. 1987 Jul;1(2):83–87. [PubMed] [Google Scholar]
  17. Wainberg M. A., Dascal A., Blain N., Fitz-Gibbon L., Boulerice F., Numazaki K., Tremblay M. The effect of cyclosporine A on infection of susceptible cells by human immunodeficiency virus type 1. Blood. 1988 Dec;72(6):1904–1910. [PubMed] [Google Scholar]
  18. Walgate R. AIDS. Politics of premature French claim of cure. Nature. 1985 Nov 7;318(6041):3–3. doi: 10.1038/318003a0. [DOI] [PubMed] [Google Scholar]
  19. Yarchoan R., Klecker R. W., Weinhold K. J., Markham P. D., Lyerly H. K., Durack D. T., Gelmann E., Lehrman S. N., Blum R. M., Barry D. W. Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex. Lancet. 1986 Mar 15;1(8481):575–580. doi: 10.1016/s0140-6736(86)92808-4. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES